MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway

Zhou,Guangyao; Lin,Wei; Fang,Peipei; Lin,Xiuzhen; Zhuge,Lu; Hu,Zhiqiu; Jin,Lingxiang

doi:10.3892/etm.2016.3542

MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway

Authors:
- Guangyao Zhou
- Wei Lin
- Peipei Fang
- Xiuzhen Lin
- Lu Zhuge
- Zhiqiu Hu
- Lingxiang Jin
View Affiliations

Affiliations: Department of Infectious Diseases, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China, Department of Surgery, Minhang Hospital, Fudan University, Shanghai 201199, P.R. China
Published online on: July 26, 2016 https://doi.org/10.3892/etm.2016.3542
Pages: 1719-1722
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the expression variation of the mouse hepatic fibrosis tissue transforming growth factor (TGF)-βl/Smads signal transduction pathway and its correlation with progression of hepatic fibrosis. The promotion effect of microRNA (miR)-10a on hepatic fibrosis and its possible mechanism was also assessed. Forty healthy female 8-week-old C57BL6/J mice were randomly divided into the control group (intraperitoneal injection of 5 µl/g normal saline, twice per week for 8 weeks) and the hepatic fibrosis group (intraperitoneal injection of 5 µl/g 10% CCI4 olive oil, twice per week for 8 weeks), with 20 mice per group. RT-PCR was used to test miR-10a expression in cells in the control and hepatic fibrosis groups. Cell culture and transfection of miR-10a mimics were conducted in the two groups and a Cell Counting Kit-8 was used to test the expression of TGF-β1 and Smad7 in hepatic fibroblasts. It was found that in comparison with the control group, miR-10a expression was significantly increased in the hepatic fibrosis group compared with the control group (P<0.05). The expression quantity of miR-10a was significantly increased in the transfection group compared with the control group (P<0.05). A high expression of miR-10a significantly improved TGF-β1 expression and reduced Smad7 expression in the hepatic fibrosis group (P<0.05). In conclusion, miR-10a expression was high in mouse hepatic tissues, transfection of miR-10a mimics significantly promoted the cell proliferation of hepatic fibrosis, and miR-10a improved hepatic fibrosis by regulating the TGF-βl/Smads signal transduction pathway.

View Figures

View References

1	Lee YA and Friedman SL: Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C? Antiviral Res. 107:23–30. 2014. View Article : Google Scholar : PubMed/NCBI
2	van der Ree MH, de Bruijne J, Kootstra NA, Jansen PL and Reesink HW: MicroRNAs: role and therapeutic targets in viral hepatitis. Antivir Ther. 19:533–541. 2014. View Article : Google Scholar
3	Kim KM and Kim SG: Autophagy and microRNA dysregulation in liver diseases. Arch Pharm Res. 37:1097–1116. 2014. View Article : Google Scholar : PubMed/NCBI
4	Havelange V, Ranganathan P, Geyer S, Nicolet D, Huang X, Yu X, Volinia S, Kornblau SM, Andreeff M, Croce CM, et al: Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML. Blood. 123:2412–2415. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M, et al: MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol. 19:2394–2402. 2012. View Article : Google Scholar : PubMed/NCBI
6	Xie T, Liang J, Guo R, Liu N, Noble PW and Jiang D: Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics. 43:479–487. 2011. View Article : Google Scholar : PubMed/NCBI
7	Uemura M, Swenson ES, Gaça MD, Giordano FJ, Reiss M and Wells RG: Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell. 16:4214–4224. 2005. View Article : Google Scholar : PubMed/NCBI
8	Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, et al: Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut. 55:415–424. 2006. View Article : Google Scholar : PubMed/NCBI
9	Heldin CH, Miyazono K and ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:465–471. 1997. View Article : Google Scholar : PubMed/NCBI
10	Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA and Brenner DA: The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology. 34:89–100. 2001. View Article : Google Scholar : PubMed/NCBI
11	Martínez Fernández EM, López-Cortés LF, Regordan C and Cordero Matía E: Meningitis by Cryptococcus neoformans in patients with HIV infection. Neurologia. 14:218–223. 1999.(In Spanish). PubMed/NCBI
12	Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P and Bedossa P: Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest. 82:767–774. 2002. View Article : Google Scholar : PubMed/NCBI
13	Long J, Wang G, Matsuura I, He D and Liu F: Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc Natl Acad Sci USA. 101:99–104. 2004. View Article : Google Scholar : PubMed/NCBI
14	Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI
15	Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C, Weiskirchen R, Frey N, et al: miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol. 58:736–742. 2013. View Article : Google Scholar : PubMed/NCBI
16	Kumar V and Mahato RI: Delivery and targeting of miRNAs for treating liver fibrosis. Pharm Res. 32:341–361. 2015. View Article : Google Scholar : PubMed/NCBI
17	Chen SL, Zheng MH, Shi KQ, Yang T and Chen YP: A new strategy for treatment of liver fibrosis: letting microRNAs do the job. BioDrugs. 27:25–34. 2013. View Article : Google Scholar : PubMed/NCBI
18	Padda RS, Gkouvatsos K, Guido M, Mui J, Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. Am J Physiol Gastrointest Liver Physiol. 308:G251–G261. 2015. View Article : Google Scholar : PubMed/NCBI
19	Rieger JK, Klein K, Winter S and Zanger UM: Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: Influence of nongenetic factors and association with gene expression. Drug Metab Dispos. 41:1752–1762. 2013. View Article : Google Scholar : PubMed/NCBI